Global Pharmaceutical Isolator Market – Industry Trends and Forecast to 2026

  • Diagnosis
  • Upcoming Reports
  • Apr 2019
  • Global
  • 283 Pages
  • No of Tables: 55
  • No of Figures: 293

Global Pharmaceutical Isolator Market By Type (Aseptic Isolators, Containment Isolators, Bio Isolators, Sampling and Weighing Isolators, Active Pharmaceutical Ingredient (API) Manufacturing Isolators, Others), Product Class Type (ISO Class 5, Class III), System Type (Open System, Closed System), Pressure Difference (Positive Pressure, Negative Pressure), Configuration (Floor Standing, Mobile, Compact, Modular, Table Top, Portable), Application (Sterility Testing, Pharmaceutical Industry, Microbiology Safety Cabinets, Sampling/ Weighing/ Distribution, Animal Laboratories, Medical Device Manufacturing, Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, Academic and Research Institutes, Hospitals, Diagnostic Laboratories), Distribution Channel (Direct Tender, Retailer), Geography (Europe, North America, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Pharmaceutical isolators are used as an industrial barrier system to manufacture drugs in contamination free environment. The pharmaceutical isolators have various applications such as microbiological test, cell therapy processing, in production of the advanced therapy medicine products (ATMP) and in weighing, filling and dispensing of the injectable sterile products. Various companies are engaged in manufacturing the isolator for the pharmaceutical industry such as Getinge AB, Skan AG and Wabash National Corporation among others. The continuous development of the pharmaceutical market in developing and developed countries and growing research and development expenditure to develop innovative drugs are all enhancing the utilization of the pharmaceutical isolators. The advanced pharmaceutical isolators and their preferences by the pharma industries, leading the major manufactures to expand their business for the development and production of isolators. For instance, in May 2017, Skan AG (Switzerland) expanded their Germany site by constructing the production plants for the safety cabinets which is majorly engaged in manufacturing the pharmaceutical isolators.

Global pharmaceutical isolator market is projected to register a substantial CAGR of 7.7% in the forecast period of 2019 to 2026.

Segmentation: Global Pharmaceutical Isolator Market

Global pharmaceutical isolator market is segmented into eight notable segments which are type, product class type, system type, pressure difference, configuration, application, end user and distribution channel.

  • On the basis of type, the market is segmented into aseptic isolators, containment isolators, bio isolators, sampling and weighing isolators, active pharmaceutical ingredient (API) manufacturing isolators and others

    • In January 2014, Extract Technology (U.K.) launched the containment and aseptic isolators, with the affordable range of systems to maintain the standard processing in the pharmaceutical, bio-tech, chemical and healthcare industry. The standard range of products SteriPharm, IsoPharm and FlexiPharm ensures high quality of manufacturing processing.

  • On the basis of product class type, the market is segmented into Class III and ISO Class 5

    • NuAire (U.S.) offers an ISO class 5 which includes the containment pharmacy isolator creates negative pressure recirculating ISO Class 5 clean air environment for aseptic compounding of hazardous drugs and minute quantities of chemotherapy drugs to meet USP 797 requirements.

  • On the basis of system type, the market is segmented into closed system and open system

    • COMECER S.p.A. (Italy) provides an open system containment solutions which are developed for the brand new glove correctly mounted with a calibrated hole device connected.

  • On the basis of pressure difference, the market is segmented into positive pressure and negative pressure

    • Tema Sinergie (Italy) offers a positive pressure, custom, controlled atmosphere which includes the aseptic processing isolator system (AP-IS) is a GMP Class A ISO 5 modular isolator system, which is basically designed for pharmaceutical production, pharmacies, quality control lab.

  • On the basis of configuration, the market is segmented into floor standing, modular, mobile, compact, table top and portable

    • Dec Group (Switzerland) provides DEC Multi-Purpose Isolator which is designed for the pharmaceutical product manufacturing of APIs and are containment based isolators to ensure APIs egress.

  • On the basis of application, the market is segmented into sterility testing, pharmaceutical industry, microbiology safety cabinets, sampling/ weighing/ distribution, animal laboratories, medical device manufacturing and others

    • ITECO s.r.l (Italy) provides the sterility testing isolators, SEI line ISOLATORS – STERILITY, the isolator basically designed for the mounting systems for performing sterility tests in which sterility conditions are maintained and monitored. The chamber is laminar flow (ULPA Filter, class ISO 5, U16), pneumatic gaskets, door interlocking, alarms to prevent the internal areas from contamination. It is used for the H2O2 measurement. The SEI model 702.5L insulator gives a pre-chamber and working chamber, which is designed to work in sterile conditions to eliminate the risk of contamination of the products or samples handled in them.

  • On the basis of end user, the market is segmented into hospitals, diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies and contract research organization.

    • Tailin (China) provides an RT1600DTC Rigid Isolator which is the new generation turbulent air flow isolator. The product is used in sterility testing in the R&D and pharmaceutical labs.

  • On the basis of distribution channel, the market is segmented into direct tender and retailer

    • In January 2019, TEMA SINERGIE S.p.A setup the Active Bio-decon Pass with the Chamber (AB-PTC) with an integrated vaporised hydrogen peroxide bio-decontamination system to AJ Vaccines (Denmark) for vaccine production. The establishment of the aseptic laboratory for AJ Vaccines (Denmark) enhancing the growth of the company.

Competitive Analysis: Global Pharmaceutical Isolator Market

Some of the major players operating in this market are Getinge AB, Chiyoda Corporation, Azbil Corporation, Germfree, MBRAUN, Wabash National Corporation, NuAire, ITECO s.r.l., COMECER S.p.A., Hosokawa, Hecht Technologie GmbH, Steriline S.r.l., Envair Limited, Vanrx Pharmasystems Inc., TEMA SINERGIE S.p.A, SKAN AG, Bioquell Inc., I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A., JACOMEX, Fedegari Autoclavi S.p.A among others.

Recent Developments:

  • In May 2018, Bioquell Inc (U.S.) recognized for the Best Health Care & Pharmaceutical PLC category of U.K. Stock Market awards.
  • In May 2016, ENVAIR LTD. announced their presence in the exhibition ANALYTICA 2016 held in Germany. The company will showcase their wide range of products Microbiological safety workbenches, PCR Thermal Cycler and Centrifuge. The showcase of their product range in international trade fair for laboratory technology, analysis, biotechnology will enhance the growth of the company.

Research Methodology: Global Pharmaceutical Isolator Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors and Pharmacologist, Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

TABLE OF CONTENTS GLOBAL PHARMACEUTICAL ISOLATOR MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 OVERVIEW OF GLOBAL PHARMACEUTICAL ISOLATOR MARKET 1.4 CURRENCY AND PRICING 1.5 LIMITATIONS 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED 2.2 GEOGRAPHICAL SCOPE 2.3 YEARS CONSIDERED FOR THE STUDY 2.4 CURRENCY AND PRICING 2.5 RESEARCH METHODOLOGY 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7 DBMR MARKET POSITION GRID 2.8 DBMR VENDOR SHARE ANALYSIS 2.9 MULTIVARIATE MODELING 2.10 PRODUCTS LIFELINE CURVE 2.11 SECONDARY SOURCES 2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL SECTOR/INDUSTRY 3.1.2 LOW OPERATIONAL COST OF PHARMACEUTICAL ISOLATORS 3.1.3 INCREASING REGULATIONS AND COST OF NONCOMPLIANCE 3.1.4 HIGH MAINTENANCE OF ASEPTIC CONDITION IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS

3.2 RESTRAINT

3.2.1 STRINGENT GOVERNMENTAL REGULATIONS

3.3 OPPORTUNITIES

3.3.1 TECHNOLOGICAL ADVANCEMENTS IN PHARMACEUTICAL ISOLATORS 3.3.2 BUSINESS EXPANSION FOR THE PHARMACEUTICAL ISOLATORS

3.4 CHALLENGE

3.4.1 AVAILABILITY OF RESTRICTED ACCESS BARRIER SYSTEMS (RABS) FOR ASEPTIC PROCESSING

4 EXECUTIVE SUMMARY 5 PREMIUM INSIGHTS 6 INDUSTRY INSIGHTS 7 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY TYPE

7.1 OVERVIEW 7.2 ASEPTIC ISOLATORS 7.3 CONTAINMENT ISOLATORS 7.4 BIO ISOLATORS 7.5 SAMPLING AND WEIGHING ISOLATORS 7.6 ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS 7.7 OTHERS

8 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE

8.1 OVERVIEW 8.2 CLASS III 8.3 ISO CLASS 5

9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE

9.1 OVERVIEW 9.2 CLOSED SYSTEM 9.3 OPEN SYSTEM

10 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE

10.1 OVERVIEW 10.2 POSITIVE PRESSURE 10.3 NEGATIVE PRESSURE

11 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION

11.1 OVERVIEW 11.2 FLOOR STANDING 11.3 MOBILE 11.4 COMPACT 11.5 MODULAR 11.6 TABLE TOP 11.7 PORTABLE

12 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION

12.1 OVERVIEW 12.2 STERILITY TESTING 12.3 PHARMACEUTICAL INDUSTRY 12.4 MICROBIOLOGY SAFETY CABINETS 12.5 SAMPLING/ WEIGHING/ DISTRIBUTION 12.6 ANIMAL LABORATORIES 12.7 MEDICAL DEVICE MANUFACTURING 12.8 OTHERS

13 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY END USER

13.1 OVERVIEW 13.2 HOSPITALS 13.3 DIAGNOSTIC LABORATORIES 13.4 ACADEMIC AND RESEARCH INSTITUTES 13.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 13.6 CONTRACT RESEARCH ORGANIZATION

14 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW 14.2 DIRECT TENDER 14.3 RETAILER

15 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY GEOGRAPHY

15.1 OVERVIEW 15.2 NORTH AMERICA

15.2.1 U.S. 15.2.2 CANADA 15.2.3 MEXICO

15.3 EUROPE

15.3.1 GERMANY 15.3.2 FRANCE 15.3.3 ITALY 15.3.4 U.K. 15.3.5 SPAIN 15.3.6 SWITZERLAND 15.3.7 RUSSIA 15.3.8 NETHERLANDS 15.3.9 BELGIUM 15.3.10 TURKEY 15.3.11 REST OF EUROPE

15.4 ASIA-PACIFIC

15.4.1 JAPAN 15.4.2 CHINA 15.4.3 INDIA 15.4.4 SOUTH KOREA 15.4.5 AUSTRALIA 15.4.6 SINGAPORE 15.4.7 MALAYSIA 15.4.8 THAILAND 15.4.9 INDONESIA 15.4.10 PHILIPPINES 15.4.11 REST OF ASIA-PACIFIC

15.5 SOUTH AMERICA

15.5.1 BRAZIL 15.5.2 REST OF SOUTH AMERICA

15.6 MIDDLE EAST AFRICA

15.6.1 SOUTH AFRICA 15.6.2 REST OF MIDDLE EAST & AFRICA

16 GLOBAL PHARMACEUTICAL ISOLATORS MARKET, COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: GLOBAL 16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 16.3 COMPANY SHARE ANALYSIS: EUROPE 16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

17 COMPANY PROFILE

17.1 SKAN AG

17.1.1 COMPANY SNAPSHOT 17.1.2 SWOT ANALYSIS 17.1.3 COMPANY SHARE ANALYSIS 17.1.4 GEOGRAPHICAL PRESENCE 17.1.5 PRODUCT PORTFOLIO 17.1.6 RECENT DEVELOPMENTS 17.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.2 COMECER S.P.A.

17.2.1 COMPANY SNAPSHOT 17.2.2 SWOT ANALYSIS 17.2.3 COMPANY SHARE ANALYSIS 17.2.4 GEOGRAPHICAL PRESENCE 17.2.5 PRODUCT PORTFOLIO 17.2.6 RECENT DEVELOPMENTS 17.2.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.3 GETINGE AB.

17.3.1 COMPANY SNAPSHOT 17.3.2 SWOT ANALYSIS 17.3.3 REVENUE ANALYSIS 17.3.4 COMPANY SHARE ANALYSIS 17.3.5 GEOGRAPHICAL PRESENCE 17.3.6 PRODUCT PORTFOLIO 17.3.7 RECENT DEVELOPMENTS 17.3.8 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.4 WABASH NATIONAL CORPORATION

17.4.1 COMPANY SNAPSHOT 17.4.2 SWOT ANALYSIS 17.4.3 REVENUE ANALYSIS 17.4.4 COMPANY SHARE ANALYSIS 17.4.5 GEOGRAPHICAL PRESENCE 17.4.6 PRODUCT PORTFOLIO 17.4.7 RECENT DEVELOPMENTS 17.4.8 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.5 A. ROVANA LTD.

17.5.1 COMPANY SNAPSHOT 17.5.2 PRODUCT PORTFOLIO 17.5.3 RECENT DEVELOPMENTS

17.6 AZBIL CORPORATION

17.6.1 COMPANY SNAPSHOT 17.6.2 REVENUE ANALYSIS 17.6.3 GEOGRAPHICAL PRESENCE 17.6.4 PRODUCT PORTFOLIO 17.6.5 RECENT DEVELOPMENTS

17.7 BIOQUELL INC

17.7.1 COMPANY SNAPSHOT 17.7.2 GEOGRAPHICAL PRESENCE 17.7.3 PRODUCT PORTFOLIO 17.7.4 RECENT DEVELOPMENTS

17.8 CHIYODA CORPORATION

17.8.1 COMPANY SNAPSHOT 17.8.2 REVENUE ANALYSIS 17.8.3 GEOGRAPHICAL PRESENCE 17.8.4 PRODUCT PORTFOLIO 17.8.5 RECENT DEVELOPMENTS

17.9 ENVAIR LIMITED

17.9.1 COMPANY SNAPSHOT 17.9.2 GEOGRAPHICAL PRESENCE 17.9.3 PRODUCT PORTFOLIO 17.9.4 RECENT DEVELOPMENTS

17.10 ESCO GROUP OF COMPANIES

17.10.1 COMPANY SNAPSHOT 17.10.2 GEOGRAPHICAL PRESENCE 17.10.3 PRODUCT PORTFOLIO 17.10.4 RECENT DEVELOPMENT

17.11 FEDEGARI AUTOCLAVI S.P.A

17.11.1 COMPANY SNAPSHOT 17.11.2 GEOGRAPHICAL PRESENCE 17.11.3 PRODUCT PORTFOLIO 17.11.4 RECENT DEVELOPMENT

17.12 GERMFREE

17.12.1 COMPANY SNAPSHOT 17.12.2 PRODUCT PORTFOLIO 17.12.3 RECENT DEVELOPMENTS

17.13 HECHT TECHNOLOGIE GMBH

17.13.1 COMPANY SNAPSHOT 17.13.2 PRODUCT PORTFOLIO 17.13.3 RECENT DEVELOPMENTS

17.14 HOSOKAWA

17.14.1 COMPANY SNAPSHOT 17.14.2 REVENUE ANALYSIS 17.14.3 GEOGRAPHICAL PRESENCE 17.14.4 PRODUCT PORTFOLIO 17.14.5 RECENT DEVELOPMENTS

17.15 ITECO S.R.L.

17.15.1 COMPANY SNAPSHOT 17.15.2 GEOGRAPHICAL PRESENCE 17.15.3 PRODUCT PORTFOLIO 17.15.4 RECENT DEVELOPMENTS

17.16 I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A.

17.16.1 COMPANY SNAPSHOT 17.16.2 REVENUE ANALYSIS 17.16.3 GEOGRAPHICAL PRESENCE 17.16.4 PRODUCT PORTFOLIO 17.16.5 RECENT DEVELOPMENT

17.17 JACOMEX

17.17.1 COMPANY SNAPSHOT 17.17.2 GEOGRAPHICAL PRESENCE 17.17.3 PRODUCT PORTFOLIO 17.17.4 RECENT DEVELOPMENTS

17.18 MBRAUN

17.18.1 COMPANY SNAPSHOT 17.18.2 GEOGRAPHICAL PRESENCE 17.18.3 PRODUCT PORTFOLIO 17.18.4 RECENT DEVELOPMENTS

17.19 NUAIRE

17.19.1 COMPANY SNAPSHOT 17.19.2 PRODUCT PORTFOLIO 17.19.3 RECENT DEVELOPMENT

17.20 OPTIMA PACKAGING GROUP GMBH / METALL+PLASTIC GMBH

17.20.1 COMPANY SNAPSHOT 17.20.2 GEOGRAPHICAL PRESENCE 17.20.3 PRODUCT PORTFOLIO 17.20.4 RECENT DEVELOPMENTS

17.21 ROBERT BOSCH GMBH

17.21.1 COMPANYSNAPSHOT 17.21.2 REVENUE ANALYSIS 17.21.3 GEOGRAPHICAL PRESENCE 17.21.4 PRODUCT PORTFOLIO 17.21.5 RECENT DEVELOPMENTS

17.22 STERILINE S.R.L.

17.22.1 COMPANY SNAPSHOT 17.22.2 PRODUCT PORTFOLIO 17.22.3 RECENT DEVELOPMENTS

17.23 TAILIN

17.23.1 COMPANY SNAPSHOT 17.23.2 PRODUCT PORTFOLIO 17.23.3 RECENT DEVELOPMENTS

17.24 TEMA SINERGIE S.P.A

17.24.1 COMPANY SNAPSHOT 17.24.2 PRODUCT PORTFOLIO 17.24.3 RECENT DEVELOPMENTS

17.25 VANRX PHARMASYSTEMS INC.

17.25.1 COMPANY SNAPSHOT 17.25.2 PRODUCT PORTFOLIO 17.25.3 RECENT DEVELOPMENTS

18 CONCLUSION 19 QUESTIONNAIRE 20 RELATED REPORTS

LIST OF TABLES GLOBAL PHARMACEUTICAL ISOLATOR MARKET

TABLE 1 OPERATING COSTS FOR ASEPTIC PRODUCTION UNDER RABS OR ISOLATOR TABLE 2 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY TYPE , 2017-2026 (USD MILLION) TABLE 3 GLOBAL ASEPTIC ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 4 GLOBAL CONTAINMENT ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 5 GLOBAL BIO ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 6 GLOBAL SAMPLING AND WEIGHING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 8 GLOBAL OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE , 2017-2026 (USD MILLION) TABLE 10 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, BY VOLUME, 2017-2026 (THOUSANDS UNIT) TABLE 11 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, BY ASP, 2017-2026 (USD) TABLE 12 GLOBAL CLASS III IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 13 GLOBAL ISO CLASS 5 IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 14 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 15 GLOBAL CLOSED SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 16 GLOBAL OPEN SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 17 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 18 GLOBAL POSITIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 19 GLOBAL NEGATIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 20 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 21 GLOBAL FLOOR STANDING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 22 GLOBAL MOBILE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 23 GLOBAL COMPACT IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 24 GLOBAL MODULAR IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 25 GLOBAL TABLE TOP IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 26 GLOBAL POR TABLE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 27 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 28 GLOBAL STERILITY TESTING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 29 GLOBAL PHARMACEUTICAL INDUSTRY IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 30 GLOBAL MICROBIOLOGY SAFETY CABINETS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 31 GLOBAL SAMPLING/ WEIGHING/ DISTRIBUTION IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 32 GLOBAL ANIMAL LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 33 GLOBAL MEDICAL DEVICE MANUFACTURING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 34 GLOBAL OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 35 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY END USER , 2017-2026 (USD MILLION) TABLE 36 GLOBAL HOSPITALS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 37 GLOBAL DIAGNOSTIC LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 38 GLOBAL ACADEMIC AND RESEARCH INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 39 GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 40 GLOBAL CONTRACT RESEARCH ORGANIZATION IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 41 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 42 GLOBAL DIRECT TENDER IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 43 GLOBAL RETAILER IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 44 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 45 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 46 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 47 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 48 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 49 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 50 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 51 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 52 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 53 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 54 U.S PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 55 U.S PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 56 U.S PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE , 2017-2026 (USD MILLION) TABLE 57 U.S PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 58 U.S PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 59 U.S PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 60 U.S PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 61 U.S PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 62 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 63 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 64 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 65 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 66 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 67 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 68 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 69 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 70 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 71 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 72 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 73 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 74 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 75 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 76 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 77 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 78 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 79 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 80 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 81 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 82 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 83 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 84 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 85 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 86 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 87 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 88 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 89 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 90 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 91 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 92 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 93 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 94 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 95 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 96 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 97 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 98 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 99 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 100 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 101 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 102 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 103 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 104 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 105 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 106 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 107 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 108 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 109 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 110 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 111 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 112 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 113 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 114 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 115 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 116 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 117 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 118 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 119 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 120 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 121 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 122 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 123 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 124 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 125 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 126 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 127 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 128 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 129 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 130 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 131 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 132 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 133 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 134 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 135 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 136 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 137 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 138 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 139 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 140 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 141 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 142 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 143 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 144 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 145 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 146 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 147 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 148 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 149 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 150 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 151 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 152 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 153 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 154 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 155 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 156 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 157 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 158 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 159 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 160 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 161 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 162 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 163 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 164 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 165 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 166 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 167 REST OF EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 168 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 169 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 170 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 171 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 172 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 173 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 174 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 175 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 176 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 177 JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 178 JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 179 JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 180 JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 181 JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 182 JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 183 JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 184 JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 185 CHINA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 186 CHINA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 187 CHINA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 188 CHINA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 189 CHINA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 190 CHINA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 191 CHINA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 192 CHINA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 193 INDIA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 194 INDIA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 195 INDIA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 196 INDIA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 197 INDIA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 198 INDIA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 199 INDIA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 200 INDIA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 201 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 202 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 203 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 204 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 205 SOUTH KOREAPHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 206 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 207 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 208 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 209 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 210 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 211 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 212 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 213 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 214 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 215 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 216 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 217 SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 218 SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 219 SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 220 SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 221 SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 222 SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 223 SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY END USER,2017-2026 (USD MILLION) TABLE 224 SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 225 MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 226 MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 227 MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 228 MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 229 MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 230 MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 231 MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 232 MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 233 THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 234 THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 235 THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 236 THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 237 THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 238 THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 239 THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 240 THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 241 INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 242 INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 243 INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 244 INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 245 INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 246 INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 247 INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 248 INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 249 PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 250 PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 251 PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 252 PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 253 PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 254 PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 255 PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 256 PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 257 REST OF ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 258 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 259 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 260 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 261 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 262 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 263 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 264 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 265 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 266 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 267 BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 268 BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 269 BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 270 BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 271 BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 272 BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 273 BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 274 BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 275 REST OF SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 276 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 277 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 278 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 279 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 280 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 281 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 282 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 283 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 284 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 285 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 286 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 287 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE , 2017-2026 (USD MILLION) TABLE 288 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 289 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 290 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 291 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 292 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 293 REST OF MIDDLE EAST PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)

LIST OF FIGURES GLOBAL PHARMACEUTICAL ISOLATOR MARKET

FIGURE 1 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: SEGMENTATION FIGURE 2 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: GEOGRAPHICAL SCOPE FIGURE 3 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: DATA TRIANGULATION FIGURE 4 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: DROC ANALYSIS FIGURE 5 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: GLOBAL VS REGIONAL ANALYSIS FIGURE 6 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: COMPANY RESEARCH ANALYSIS FIGURE 7 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: INTERVIEWS BY REGION AND DESIGNATION FIGURE 8 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: DBMR MARKET POSITION GRID FIGURE 9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: DBMR VENDOR SHARE ANALYSIS FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PHARMACEUTICAL ISOLATOR MARKET FIGURE 11 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: MARKET SEGMENTATION FIGURE 12 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL AND HIGH MAINTAINACE OF ASEPTIC CONDITION IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS ARE EXPECTED TO DRIVE THE GLOBAL PHARMACEUTICAL ISOLATOR MARKET IN THE FORECAST PERIOD OF 2019 TO 2026 FIGURE 13 ASEPTIC ISOLATOR IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PHARMACEUTICAL ISOLATOR MARKET IN 2019 & 2026 FIGURE 14 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY TYPE , 2018 FIGURE 15 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY PRODUCT CLASS TYPE, 2018 FIGURE 16 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY SYSTEM TYPE, 2018 FIGURE 17 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY PRESSURE DIFFERENCE, 2018 FIGURE 18 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY CONFIGURATION, 2018 FIGURE 19 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY APPLICATION, 2018 FIGURE 20 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY END USER, 2018 FIGURE 21 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY DISTRIBUTION CHANNEL, 2018 FIGURE 22 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018) FIGURE 23 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY REGION (2018) FIGURE 24 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY REGION (2019 & 2026) FIGURE 25 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY REGION (2018 & 2026) FIGURE 26 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019-2026) FIGURE 27 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018) FIGURE 28 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018) FIGURE 29 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2019 & 2026) FIGURE 30 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018 & 2026) FIGURE 31 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019-2026) FIGURE 32 EUROPE PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018) FIGURE 33 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018) FIGURE 34 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2019 & 2026) FIGURE 35 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018 & 2026) FIGURE 36 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019-2026) FIGURE 37 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018) FIGURE 38 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018) FIGURE 39 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2019 & 2026) FIGURE 40 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018 & 2026) FIGURE 41 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019-2026) FIGURE 42 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018) FIGURE 43 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018) FIGURE 44 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2019 & 2026) FIGURE 45 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018 & 2026) FIGURE 46 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019 - 2026) FIGURE 47 MIDDLE EAST AFRICA PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018) FIGURE 48 MIDDLE EAST AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018) FIGURE 49 MIDDLE EAST AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2019 & 2026) FIGURE 50 MIDDLE EAST AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018 & 2026) FIGURE 51 MIDDLE EAST AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019-2026) FIGURE 52 GLOBAL PHARMACEUTICAL ISOLATORS MARKET: COMPANY SHARE 2018 (%) FIGURE 53 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET: COMPANY SHARE 2018 (%) FIGURE 54 EUROPE PHARMACEUTICAL ISOLATORS MARKET: COMPANY SHARE 2018 (%) FIGURE 55 ASIA-PACIFIC PHARMACEUTICAL ISOLATORS MARKET: COMPANY SHARE 2018 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART